These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 31249264)

  • 1. Additive and nonadditive effects of salmon calcitonin and omega-3 fatty acids on antioxidant, hematological and bone and cartilage markers in experimental diabetic-osteoarthritic rats.
    Adeyemi WJ; Olayaki LA
    Chin J Physiol; 2019; 62(3):108-116. PubMed ID: 31249264
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of single or combined administration of salmon calcitonin and omega-3 fatty acids vs. diclofenac sodium in sodium monoiodoacetate-induced knee osteoarthritis in male Wistar rats.
    Adeyemi WJ; Olayaki LA
    J Basic Clin Physiol Pharmacol; 2017 Nov; 28(6):573-582. PubMed ID: 28917083
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of Salmon Calcitonin and Omega - 3 Fatty Acids on Glucoregulatory Indices, Lipid Profile and Antioxidant Markers in Experimental Knee Osteoarthritis in Wistar Rats.
    Adeyemi WJ; Olayaki LA
    Niger J Physiol Sci; 2017 Dec; 32(2):179-188. PubMed ID: 29485639
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synergistic and non-synergistic effects of salmon calcitonin and omega - 3 fatty acids on antioxidant, anti-inflammatory, and haematological indices in diabetic rats.
    Adeyemi WJ; Olayaki LA
    Biomed Pharmacother; 2018 Mar; 99():867-875. PubMed ID: 29710486
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Calcitonin and Omega-3 Fatty Acids Exhibit Antagonistic and Non-Additive Effects in Experimental Diabetes.
    Adeyemi WJ; Olayaki LA
    Pathophysiology; 2018 Jun; 25(2):117-123. PubMed ID: 29449103
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Co-administration of omega-3 fatty acids and metformin showed more desirable effects than the single therapy on indices of bone mineralisation but not gluco-regulatory and antioxidant markers in diabetic rats.
    Adeyemi WJ; Olayaki LA; Abdussalam TA; Fabiyi TO; Raji TL; Adetunji AA
    Biomed Pharmacother; 2020 Jan; 121():109631. PubMed ID: 31715372
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diabetes escalates knee osteoarthritis in rats: Evidence of adaptive mechanism.
    Adeyemi WJ; Olayaki LA
    Environ Toxicol Pharmacol; 2018 Jul; 61():1-7. PubMed ID: 29803977
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A hyaluronic acid-salmon calcitonin conjugate for the local treatment of osteoarthritis: chondro-protective effect in a rabbit model of early OA.
    Mero A; Campisi M; Favero M; Barbera C; Secchieri C; Dayer JM; Goldring MB; Goldring SR; Pasut G
    J Control Release; 2014 Aug; 187():30-8. PubMed ID: 24837189
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of single or combined induction of diabetes mellitus and knee osteoarthritis on some biochemical and haematological parameters in rats.
    Adeyemi WJ; Olayaki LA
    Exp Mol Pathol; 2017 Oct; 103(2):113-120. PubMed ID: 28757388
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Oral salmon calcitonin enhances insulin action and glucose metabolism in diet-induced obese streptozotocin-diabetic rats.
    Feigh M; Hjuler ST; Andreassen KV; Gydesen S; Ottosen I; Henriksen JE; Beck-Nielsen H; Christiansen C; Karsdal MA; Henriksen K
    Eur J Pharmacol; 2014 Aug; 737():91-6. PubMed ID: 24858364
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Oral salmon calcitonin induced suppression of urinary collagen type II degradation in postmenopausal women: a new potential treatment of osteoarthritis.
    Bagger YZ; Tankó LB; Alexandersen P; Karsdal MA; Olson M; Mindeholm L; Azria M; Christiansen C
    Bone; 2005 Sep; 37(3):425-30. PubMed ID: 16005273
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Oral salmon calcitonin reduces Lequesne's algofunctional index scores and decreases urinary and serum levels of biomarkers of joint metabolism in knee osteoarthritis.
    Manicourt DH; Azria M; Mindeholm L; Thonar EJ; Devogelaer JP
    Arthritis Rheum; 2006 Oct; 54(10):3205-11. PubMed ID: 17009253
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Salmon Calcitonin Attenuates Degenerative Changes in Cartilage and Subchondral Bone in Lumbar Facet Joint in an Experimental Rat Model.
    Gou Y; Tian F; Kong Q; Chen T; Li H; Lv Q; Zhang L
    Med Sci Monit; 2018 May; 24():2849-2857. PubMed ID: 29748528
    [TBL] [Abstract][Full Text] [Related]  

  • 14. N-3 fatty acids modulate antioxidant status in diabetic rats and their macrosomic offspring.
    Yessoufou A; Soulaimann N; Merzouk SA; Moutairou K; Ahissou H; Prost J; Simonin AM; Merzouk H; Hichami A; Khan NA
    Int J Obes (Lond); 2006 May; 30(5):739-50. PubMed ID: 16418759
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mice over-expressing salmon calcitonin have strongly attenuated osteoarthritic histopathological changes after destabilization of the medial meniscus.
    Sondergaard BC; Catala-Lehnen P; Huebner AK; Bay-Jensen AC; Schinke T; Henriksen K; Schilling S; Haberland M; Nielsen RH; Amling M; Karsdal MA
    Osteoarthritis Cartilage; 2012 Feb; 20(2):136-43. PubMed ID: 22122987
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Calcitonin treatment is associated with less severe osteoarthritis and reduced toll-like receptor levels in a rat model.
    Li J; Xie ZG; Xie Y; Dong QR
    J Orthop Sci; 2014 Nov; 19(6):1019-27. PubMed ID: 25146000
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effect of oral salmon calcitonin delivered with 5-CNAC on bone and cartilage degradation in osteoarthritic patients: a 14-day randomized study.
    Karsdal MA; Byrjalsen I; Henriksen K; Riis BJ; Lau EM; Arnold M; Christiansen C
    Osteoarthritis Cartilage; 2010 Feb; 18(2):150-9. PubMed ID: 19747581
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Oral salmon calcitonin reduces cartilage and bone pathology in an osteoarthritis rat model with increased subchondral bone turnover.
    Nielsen RH; Bay-Jensen AC; Byrjalsen I; Karsdal MA
    Osteoarthritis Cartilage; 2011 Apr; 19(4):466-73. PubMed ID: 21251986
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Calcitonin directly attenuates collagen type II degradation by inhibition of matrix metalloproteinase expression and activity in articular chondrocytes.
    Sondergaard BC; Wulf H; Henriksen K; Schaller S; Oestergaard S; Qvist P; Tankó LB; Bagger YZ; Christiansen C; Karsdal MA
    Osteoarthritis Cartilage; 2006 Aug; 14(8):759-68. PubMed ID: 16549372
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of calcitonin in early and late stages of experimentally induced osteoarthritis. A histomorphometric study.
    Papaioannou NA; Triantafillopoulos IK; Khaldi L; Krallis N; Galanos A; Lyritis GP
    Osteoarthritis Cartilage; 2007 Apr; 15(4):386-95. PubMed ID: 17157537
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.